Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Neurofibroma, Plexiform 3Neurofibromatosis 1 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Radiation Fibrosis Syndrome 1Precancerous Conditions 1Pneumonia 1Neurofibromatoses 1Nerve Sheath Neoplasms 1Neoplasms 1Myofibroma 1Lymphedema 1Leiomyoma 1Colorectal Neoplasms 1Acute Lung Injury 1

Interventions

ulipristal acetate 20Uterine Myomectomy 19telapristone acetate 18vilaprisan 12relugolix 12Leuprolide 11Uterine Artery Embolization 10estradiol, norethindrone drug combination 9asoprisnil 9Estradiol 8elagolix 7Tranexamic Acid 7Mifepristone 7Bupivacaine 7ulipristal 6Norethindrone Acetate 6Hysterectomy 6Saline Solution 5linzagolix 4epigallocatechin gallate 4Sodium Chloride 4Misoprostol 4Letrozole 4Vitamin B 6 3Tablets 3Surveys and Questionnaires 3Sugars 3Radiofrequency Ablation 3Lidocaine 3Hysteroscopy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leiomyoma × pirfenidone × Clear all
NCT00332033 2017-07-02

Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
32 enrolled

Leiomyoma, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡